The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ICICI Prudential Mutual Fund, through its various schemes, bought 19,98,400 equity shares (3.77%) of Thyrocare Technologies Ltd on October 24, 2025 in the secondary market. This raised the fund's total holding from 8,25,490 shares (1.56%) to 28,23,890 shares (5.33%), crossing the 5% disclosure threshold under SEBI SAST Regulations. The acquirer is not part of the promoter/promoter group and stated the purchase is purely from an investment perspective, with no intent to seek control. The disclosure was filed by Rakesh Shetty, Chief Compliance Officer of ICICI Prudential AMC, on October 27, 2025.
This is a significant institutional buying signal — a major mutual fund house has increased its stake to over 5%, which generally reflects confidence in the company's fundamentals. For shareholders, it means increased institutional support and potentially positive near-term sentiment, though the acquirer has clarified no controlling interest is being sought.